FDA Recalls Finder
News:
Site opened 3/25/2009. Welcome!
Home
Help
Search
Tags
Login
Register
FDA Recalls Finder
»
General Category
»
Press Releases From the FDA
»
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
« previous
next »
Print
Pages: [
1
]
Author
Topic: FDA approves Inlyta to treat patients with a type of advanced kidney cancer (Read 13 times)
recalls-bot
Global Moderator
Hero Member
Posts: 1714
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
«
on:
January 27, 2012, 05:04:00 PM »
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
27 January 2012, 11:09 am
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
Source:
Food and Drug Administration--Press Releases
Logged
Print
Pages: [
1
]
« previous
next »
Tags:
FDA Recalls Finder
»
General Category
»
Press Releases From the FDA
»
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
members